1 ❏ griseofulvin
2 ❏ rifampicin
3 ❏ warfarin
A ❏ if 1, 2 and 3 are correct
B ❏ if 1 and 2 only are correct
C ❏ if 2 and 3 only are correct
D ❏ if 1 only is correct
E ❏ if 3 only is correct
Experts at different times have analysed the colours of people’s urine, and they have come to the conclusion that urine colour has a lot to say about an individual’s health status.
Aside the fact that urine is a veritable human fluid from which diseases could easily be detected from, the colour also reveal to a greater extent, the health condition of the carrier.
This explains the rationale behind the analysis conducted by a London-based medical practitioner, Dr Luke Powles from Bupa Health Clinics, on human urine colours and its health implications.
According to Dr Powles, urine colour indicates people’s hydration levels, with dark yellow colours suggesting the need for an instant glass of water. Red and even green shades may be a sign of a more serious health problem, he adds.
Dr Powles, who spoke via an article on Daily Mail, emphasised the need for most people to drink between 1.5 and two litres of water a day, and should avoid dehydrating, sugary drinks like soda and alcohol.
Pale straw
This is the ideal urine colour and demonstrates a person is sufficiently hydrated, Cosmopolitan reported.A lighter colour than this indicates the individual is probably drinking more water than they need to.

Although usually harmless, this may cause them to urinate overly frequently.
Dark yellow
Amber-coloured urine suggests somebody is dehydrated and should drink water as soon as possible.
Green
Although it may be alarming, green urine is usually harmless and occurs as a result of eating particular foods, such as asaparagus or artifical colourings.
In rare cases, however, green urine is a sign of the rare genetic disease familial hypercalcemia, which causes abnormally high calcium levels in the blood. Green urine can also occur as a side effect of certain medications.
Red
Red urine is also usually due to eating certain foods, such as beetroot.
Yet, it can also be due to blood, such as during menstruation or, in more serious cases, infections or even cancers.
If people are unable to link their red urine to a food they have eaten recently, they should visit their GP as soon as possible.
Snoring is a common sleep problem with significant public health concerns. In fact, snoring among Nigerians has been associated with multiple factors. While the risk factors of snoring range from hypertension, to cerebrovascular disease, heart disease and daytime somnolence, experts have called for increase in awareness campaign about the condition.
Snoring is caused by air vibrating in the upper respiratory tract. There are many recommended snoring remedies, but which are the most effective?

Dr Daniel Murrell of Medical News Today recently reviewed some practical methods to ease or cure the condition. They are listed below:
The following lifestyle changes and tips may reduce or stop a person’s snoring.
Overweight individuals are more likely to snore. Fatty tissue and poor muscle tone, particularly around the throat, contribute to snoring.Eating a calorie-controlled, healthful diet and regularly exercising are the best ways to lose weight.
A person is more likely to snore if they lie on their back, which can cause the tongue to move to the back of the throat. This makes breathing harder and can cause the vibrations of snoring.
Sleeping on one side may allow the air to flow more smoothly, reducing the vibrations. This may either stop the sound of a snore or make it quieter.
In addition to harming overall health, smoking irritates the airways, and this can make snoring worse.If a person smokes, quitting may help them to snore less, if at all.
Drinking a significant amount of alcohol relaxes the throat muscles. When these muscles relax, they are more likely to vibrate. Avoiding alcohol before bed may reduce or stop snoring.
Sedative medications, or sleeping pills, can lead to very deep sleep. This may have a relaxing effect on the throat muscles and cause snoring. A doctor can recommend healthful ways to ensure a good night’s sleep.
Elevating the head using additional pillows may help to open the airways, reducing or eliminating snoring. Marketers offer pillows designed to prop up the body and prevent snoring. These are available to buy online.
An allergic reaction may lead to congestion and blocked airways. This can make snoring worse. If a person’s snoring is caused by allergies, getting effective treatment can help.
Consultant Nephrologist, Theophillus Umeizudike, on Thursday, said women are more at risk of developing Chronic Kidney Disease than men.
Mr. Umeizudike, who works at Lagos State University Teaching Hospital, Ikeja, made this known in an interview with News Agency of Nigeria (NAN) in Lagos.
He spoke against the backdrop of the World Kidney Day marked annually on the second Thursday in March.
The 2018 WKD coincides with International Women’s Day (IWD), marked annually on March 8 and the theme for this year’s WKD is “Kidneys and Women’s Health: Include, Value, Empower.”

The consultant said factors such as pregnancy induced hypertension, unwanted pregnancies resulting to abortion, and auto-immune diseases put women at risk of kidney disease.
Mr. Umeizudike added that “women with progressing pregnancies may be at risk of pregnancy induced hypertension which usually tends to affect teenagers or those in their early 20s and late 40s.
“Also, those who have had many children may be at risk of pregnancy induced hypertension, a risk factor for pre-eclampsia or eclampsia and these can impact on both mother and child.
“The other aspect of women’s health that makes them prone to kidney disease is that women tend to have auto-immune diseases, a condition where the body fights itself.
“The diseases common to women include systemic lupus erythematosus, arthritis, and many other disorders which affect the kidneys.”
He, therefore, advised women of reproductive age and were pregnant to register in a health facility to be well monitored during pregnancy.
He also advised women who had unwanted pregnancies not to terminate them as it could result to infections which could cause kidney diseases.
He noted that “one in five per cent of women may be affected by pregnancy induced hypertension and so they need to be detected early to prevent complications.
“Usually, women who were treated for eclampsia during pregnancy may have their blood pressures normalised after delivery.
“However, some years down the line, the woman may be at risk of developing hypertension, a risk factor for kidney disease.
“So, if treated during pregnancy, women still need to be monitored to be sure she is not developing hypertension or it is not persisting.
“Women should also imbibe the culture of checking their health status on yearly basis to be sure that there is nothing wrong with their vital organs,” he said.
According to an online journal — Kidney International — WKD and IWD commemorated on the same day is an opportunity to highlight the importance of women’s health and particularly their kidney health.
The journal is the official journal of the International Society of Nephrology.
It stated that “on its 13th anniversary, WKD promotes affordable and equitable access to health education, health care, and prevention for all women and girls in the world.
“The coinciding of WKD and IWD offers an opportunity to develop and define best practices and future research agendas.
“Ultimately, to optimise outcomes of present and future generations living with or at risk for kidney disease.
“Advocating for improved access to care for women is critical to maintain the health of families, communities and populations.”
(NAN)
In this exclusive interview with Pharmanews, Mrs Chinenye Okoronkwo, head of marketing, Consumer Products, Neimeth International Pharmaceuticals Plc, talks about stress and why she considers Homtamin Ginseng Capsule the most effective remedy for combating it. Excerpts:
Neimeth International Pharmaceuticals Plc is a public quoted company with the Nigerian Stock Exchange. As a foremost indigenous, innovative Nigerian company with global perspectives, the company is involved in the manufacturing, marketing and distribution of quality pharmaceuticals and veterinary products in over 20 therapeutic product ranges in Nigeria, West Africa and internationally. The company is the resultant company from the Mazi Sam I. Ohuabunwa led Management-Buy-Out of the 60 per cent equity holding of Pfizer Incorporation, New York, USA, in Pfizer Products Plc, which took place in May 1997 when Pfizer Incorporation in pursuit of its global repositioning strategy, divested 60 per cent equity in Pfizer Products Plc. in favour of the existing management.

Homtamin G Capsules is an anti- stress formulation that comprises multivitamins, minerals, aloe extract and Korean ginseng extract, which work synergistically to reduce the effects of stress and its deleterious consequences as is the case with prolonged stress if left unmanaged. The most tasked vitamins during stress are B complex, Folic and Vitamin C. If these are replenished, they will relieve the weakness and debility that come with stress. So, Homtamin G Capsule is capable of controlling stress and its after-effects because it contains standardised ginseng extracts and minerals that are particularly tasked in the body when stressed.
Meanwhile, the products was introduced as part of our commitment towards the provision of a better quality of life for Nigerians through adequate management of stress. Also, having observed that the incidence of sudden death was becoming higher among top executives, probably as a result of the high level of responsibility placed on them through decision-making and risk-taking, we decided to introduce the product.
Homtamin G Capsule comprises triterpenoid saponins collectively called Ginsenosides, which is believed to be the most important active constituents. It also has Korean Ginseng, which is very rich in Ginsenosides and this makes the product stand out among others in its therapeutic field. Korean Ginseng profile is essentially different from other stimulants. While others are active under most situations, Korean Ginseng reveals stimulatory action only under the challenges of stress.
Within the first two years that Homtamin G Capsule was introduced into the Nigerian Market, it grew from 87 per cent to 383 per cent. It has maintained this positive growth trend since then, and more recently in 2017, it also grew by 145 percent, while it has also maintained an impressive achievement of targeted sales volumes.
Stress, in very simple terms, is anything that tends to create little disturbance in you. It does not matter how big or little it is, even something as insignificant as painful shoes, bad odour and the likes. However, medically, stress is the way our body responds to pressure and we can also define it as a situation in which everyday demands or tasks exceed our adjustive capacity. Examples of stress include financial, marital, work and health-related stress. We all have our ways of coping with change, so the causes of stress can be different for each person.
Stress can be either good or bad. Good stress positively compels people to action, e.g. to study for an exam, or a baby learning to crawl, whereas bad stress results in negative feelings such as distrust, anger and depression e.g. the death of a loved one. Bad stress can be acute or chronic and may lead to serious health problems or death.
Stress is a silent killer, but the good news is that it can be managed, and in managing it, it could be physical or mental. One can manage stress perfectly by engaging in physical exercise like football, and one can also engage in mental exercise like playing chess, scrabble and so on. These things are meant to remove your mind from what is worrying you and that is why doctors usually suggest this whenever people visit the hospital.
We also have relaxation, religious beliefs and conviction, and through counselling. It can also be managed by taking nutritional supplements, which come by way of multivitamin, minerals and antioxidants, just like we have in Homtamin Ginseng Capsule.
Nimartem, NCP and Ciklavit are other major brands from Neimeth International Pharmaceuticals Plc that are well known in Nigeria and their rapidly growing popularity is due to their efficacy and reliability.Ciklavit is the first indigenous nutritional supplement for the management of sickle cell anaemia. A natural food extract with essential amino acids, vitamins and minerals, which is derived from a species of local beans known as cajanus cajan, it is endowed with potent anti-sickling properties that reduces frequency and severity of painful crises.
NCP is an antiseptic and also doubles as a disinfectant that contains halogenated phenols, sodium salicylate and phenolic compounds. Halogenated phenol possesses anti-microbial activity, while sodium salicylate has anti-inflammatory and analgesic effect thus reducing pain, while Nimartem is an Artemisinin Combination Therapy that has Artemether and Lumefantrine as its active constituents and is indicated for the treatment of uncomplicated falciparum malaria.
It’s funny how the harder I work, the more successful I become. – Jack Warner
The Scripture talks about sowing and reaping in Galatians 6:7: ‘‘Therefore whatsoever a man soweth, that also shall he reap.’’ The law of sowing and reaping is one of the greatest laws of success. You cannot reap what you did not sow; therefore you are as lucky as the efforts you invest in a task.
The logic also goes that you are luckier when you work harder. You reap more when you sow more. Your harvest is proportionate to the amount of seed you planted. You earn more when you invest more. You receive more when you give more.
Hard work leads to success
I read in Brian Tracy’s 100 Absolutely Unbreakable Laws of Business Success that in Dr Thomas Stanley’s The Millionaire Next Door, he reports that almost every one of the self-made millionaires in America told him that their success was due to hard work than any other factor. Hard work is a necessity in the ladder of success.
I believe that when opportunity meets preparation, the result is success. It takes hard work to ensure preparation and it takes preparation to attain success. The two – hard work and success – are interwoven. They are closely related. Hard work leads to success. No one stumbles on success. I have always maintained that success is a deliberate design. Success is not a 100m dash; it is a marathon. You must be willing to go all the way. You must be ready to pay the success Price. You must be willing to persevere until you attain your goals. It won’t be easy. The path to real success is usually tough but it’s worth the toil because hard work pays.
Mark Zuckerberg once said, ‘‘Nothing ever comes out fully formed.’’ Success does not locate people’s addresses. Success only locates the people who attract it. The way to attract success is through hard work, clarity of goal and positive attitude. You just have to create the world you desire. You must take your time to form your dream world.
Success is a summation of deliberate actions taken over a period of time. Success doesn’t just happen. The harder you work, the luckier you get. No one lies in his bed and expect an income without doing anything. Life requires that you pay your dues before reaping the fruits. You must plant before you reap. Nothing happens by accident. Success is planned and pursued.
Success is a function of hard work and adhering to success principles. The man who works hard is naturally going to be luckier than the man who idles away and expects that a miracle will happen. Thomas Jefferson wrote, ‘‘Determine never to be idle. No person will have occasion to complain of the want of time, who never loses any. It is wonderful how much may be done, if we are always doing.’’
When you keep doing, you keep achieving. A hard working individual knows how to till the ground. He believes there is dignity in labour. He takes calculated risks and makes a lot of efforts to succeed. It takes consistent efforts before arriving at success. The man who fails to work tries nothing and achieves nothing.
Contemporary thinkers agree that people who are not taking risk are the main risk takers. This is the philosophy of successful people. I agree with this viewpoint. The logic is simple, the more risk you take, the harder you work and the more you are exposed to options that lead to success and, of course, the more you succeed.
Hard working people dare their environments to discover the hidden treasures. They are big dreamers. Working hard is being successful at the moment. You are a success once you can work hard. Nature has a way of compensating hard working folks.
Salesmen often encounter series of challenges. They come across these challenges in order to excel in their careers. It takes overcoming obstacles to win a competition. Winning doesn’t come easy. Salesmen are expected to overcome the challenges they encounter on the way. They are expected to outsmart the activities of competitors.
Stakeholders expect salesmen to come out successful in their sales activities. No one succeeds in this kind of demanding environment if he is not hard working. An individual who works hard puts himself on the driver’s seat; he takes charge. Till the ground!
Deacon Adebowale Robert Tade is a pharmacist of repute whose vast experience in pharma marketing, administration and human resource management is renowned. In this interview with Adebayo Folorunsho-Francis, the former Pfizer Specialties and Livestock Feeds Limited czar chronicled his journey, trials and triumph with the multinational company. Excerpts:
My first experience was with Burroughs Wellcome. I was one of those who first launched Septrin, Actifed, Neosporins and some others. I later moved up north and worked with Beecham. At a point, I wasn’t satisfied with the state of things at the company because I was the only sales representative covering most of the then northern states up to Lake Chad. I was always busy travelling from one end to the other. Eventually I got fed up. One day, I paused and asked myself what I was doing in the Chad area. I left the company and returned to the south.
At what point did you join Pfizer?
I got an appointment with Pfizer after I went back to the south in 1973 as a medical representative. I got promoted as the ethical product manager in 1975, after some very competitive on-the-job tests and interviews. Thanks to Pharm. Douglas Egbuonu for his forthrightness and the Late Pharm. Dr Fred Adenika for his thoroughness and leadership. I moved in quick succession from product manager in 1976 to marketing manager in 1978 and head of the pharmaceutical division as division manager in 1981. By dint of hard work, I worked my way up to becoming Pfizer’s deputy managing director in 1985, the first Nigerian pharmacist to be so appointed and also elected to the Board of Directors of the company.
I wouldn’t say my position as DMD was my biggest achievement. I happened to be the first Nigerian pharmacist to be on the board of Pfizer Products Plc in 1985. You can imagine all the pharmacists around me then. They were full of joy. The likes of Sam Ohuabunwa, Ajibade Adeshina and the late Dr Olukoya. We had all been looking forward to the time when a Nigerian would be on the board of great Pfizer. We had some pharmacists who passed through Pfizer but never made it to the board. They were there partly as managers.

In those days, someone like Julius Adelusi-Adeluyi was a general manager but was never brought to the board. In fact, he did not stay for too long. A very energetic guy, Julius was always on the move. I was then the deputy managing director for Pfizer at that time. But I didn’t see it as my greatest achievement actually. In fact, when I relocated to livestock feed to be chairman and managing director, I still did not see that as my biggest achievement. What many people missed out on my profile is that in 1998, I became the country manager/managing director of Pfizer Anglophone West Africa. That is one area I know many people miss out when writing about me. I ran Livestock Feeds from 1998 and retired in 2005. I would see myself as the longest serving Nigerian pharmacist on the board of Pfizer.
What then led to the management buy-out that allegedly divided Pfizer?
There is what we call buy-over (management buy-out) when Pfizer sold 60 per cent equity in Livestock Feeds Plc and in Pfizer Products Plc. That was done in 1992/1993 or thereabout. It was at that time that Neimeth International bought 60 per cent of Pfizer’s shareholdings. Another group also came forward to buy over Pfizer’s 50 per cent equity in Livestock Feeds Plc and I was named the chairman and managing director of the then Livestock Feeds Plc at that time.
My good professional colleague and respected junior, Mazi Sam Ohuabunwa, was made chairman/managing director of Pfizer Products Plc. In 1998, Pfizer thought it fit that their 100 per cent other outfit, Pfizer Specialties Limited, needed a Nigerian head and I was appointed chairman/managing director of Pfizer Specialties Limited.
When Pfizer divested from Nigeria, all their researched products began to be promoted, sold and managed by Pfizer Specialties Limited to date. The old products were left with Neimeth while the new ones (researched products) were put in charge of Pfizer Specialties Limited.
The person managing Pfizer Specialties, one Frenchman, whose name I cannot recall at the moment, was reassigned to another location in Pfizer Europe. That was how I became the chairman/managing director of Pfizer Specialties. It was in that position that the likes of Lere Baale were reporting to me as marketing director while people like Yinka Obadina were reporting to me as finance director as well as the human resource manager and other directors. I was in that position till July 2005.
In all, I spent about eight years on that seat. That probably made me the longest serving Nigerian Pharmacist as chairman and managing director of Pfizer Specialties and many of its outfits anyway. I believe the reason such key information is often missed out is probably because I still retained my chairmanship of Livestock Feeds Plc (non-executive chairman).
Do you now understand? That indeed overshadowed my position as chairman/managing director of Pfizer Specialties Limited. So that is me!
Which did you find most challenging among all the appointments you had?
If you ask for the most challenging, I would say the one I had as chairman/managing director of Pfizer Specialties Limited. Beside Nigeria, I was in charge of Ghana, Liberia, Sierra Leone and The Gambia. Not just that, I was on the board of the companies there.
How many Nigerians do we have, even to date, with such responsibilities – chairman/managing director of their companies in Anglophone West Africa? That was my job and I found it quite challenging. We were actively on ground, not on paper.
Prior to my assumption to that office, such responsibilities attached to the position, including the ones held by the Frenchman, were merely seen on paper. But now, the actual work had begun. We operated in Ghana, Liberia, Sierra Leone, The Gambia and, of course, Nigeria. Such a huge task it was!
You can imagine the several times we travelled there, we made use of Slok Airline that belonged to that former governor of Nigeria (Orji Uzor Kalu). We would fly Slok Airline to Ghana; it was that same Slok that would take us to Sierra Leone and other countries.
You remember that I told you I had able lieutenants like Lere Baale, who is still quite active and energetic to date; the finance director and also my marketing directors. Of course, we made sure that we had good people on ground to do the job. I guess that aptly sums up my 32 years of working with Pfizer.
Many people see the newly appointed NAFDAC boss as another Dora Akunyili. Do you support this notion?
Well, Dora stood for something which was passion. Passion for the job at that time. Fake and counterfeit drugs everywhere. She understood the hazard and the impact on Nigerians. She knew all those and still developed that passion to tackle it. It was that passion that saw her through the hazard of the job successfully.
Dora knew a lot about all these fake drugs, substandard medicines, parallel imports and those things that were wrong with the system. And she came out to do a corrective surgery and sanitised the system. The man who came after her (Dr Paul Orhii) was just another appointment. He came with no passion! He was busy with his people thinking, ‘Oh! This is a big job of us (doctors).’
So, this new lady (Prof. Mojisola Adeyeye) being a pharmacist, I have no doubt that she too will develop the passion. The keyword here is passion. Dora had it; I believe this one too will do exactly the same thing. We need someone who is very disciplined, just as Dora was. If I may ask: Who could attempt to bribe a Dora? I repeat, who? (laughs). Don’t forget our motto that says ‘As men of honour, we join hands to make Nigeria great again!”
It was Donald Trump, president of the United States, who recently said, “Without passion you don’t have energy, without energy you have nothing”. Thus, for Isah Dahiru, president of the Pharmaceutical Association of Nigeria Students (PANS), Ahmadu Bello University, (ABU), Zaria, Kaduna State, what drives his passion for Pharmacy is, according to him, the desire to care for the disadvantaged in society. In this interview with Pharmanews, the 500-level scholar revealed the peculiarities of studying Pharmacy in the northern part of the country, as well as the achievements and plans of his administration. Excerpts:
So many factors motivated me to study Pharmacy, but the most notable among them was my encounter with a pharmacist who used to visit my grandfather, some years back, to collect some herbal leaves that were mostly common in the north. There was a day I asked him, “What are you doing with these northern herbal leaves?” His response was that they were more effective than conventional medicines. Thereafter, he inspired and triggered in me the passion for Pharmacy. He made me to understand that, after my studies, I could standardise the herbal drugs.
Another reason I chose to study Pharmacy is that I want to establish my own pharmaceutical premises and take care of orphans, especially the almajiris (local name for urchins in the north), the homeless and those people with mental health challenges that are roaming about in dirty clothes, without shelter and without a good life.
I sometimes imagine the kind of hardship being faced by those who fall sick and have no means of taking care of themselves. I want to have my private establishment to celebrate the beauty of life with the less privileged.

My best moment in life is when I am doing something that will help somebody. When I was in 200 level, I had the opportunity to represent my class in the pharmacy parliament, a legislative arm of PANS. Also, in my 300 level, I was elected as the financial secretary of PANS-ABU. I also served as the editor-in-chief of Pharmaceutical Muslim Students Society of Nigeria (PMSSN) ABU chapter.
In my fourth year, I was elected as the contact person and Nigeria’s official representative to the International Pharmaceutical Students Federation (IPSF-Netherlands), concurrently serving as secretary general of PMSSN. The journey was not an easy one, but we made it all the way.
At the end of my 400 level, I contested for the presidential seat against two other contestants and emerged as the winner. My main reason for participating in my local chapter PANS politics is to deliver an administration that will maximise the potentials of my fellow students, both academically and morally, and to also make a history in the sands of time with regards to students’ welfare and accord them necessary opportunities that will make them better in their societies.
We were inaugurated in January 2018. Despite that we have achieved so many things, notable among which was the free registration exercise carried out for newly admitted pharmacy students. We have recorded massive success in this regard.
We have our year planner which contains an array of our activities from January 2018 to August 2018 when we shall be handing over to the next administration. Our year planner contains projects which we have divided into recurrent and capital. Our recurrent projects are the activities that we hope to carry out on day-to-day basis. These include sensitisation programmes on drug abuse and irrational use of medicines, which will include drug tests, health outreaches, media reach-outs and many more. Provisions of notebooks, faculty cleaning exercise, academic symposia, recreational activities and talent hunts are all part of our recurrent activities.
Our capital projects are mainly structural establishments, such as establishment of students’ recreational garden, construction of faculty sign board, fluorescent inscription in all classes, door tags for staff offices, modification of our walkways and renovation of our PANS secretariat to mention a few. The journey has just started but we are much more than determined to fulfil on our promises.
The present Faculty of Pharmaceutical Sciences, ABU, Zaria, started as a Department of Pharmacy and Pharmacology under the Faculty of Sciences in 1968. Over the years, what would you say have been the challenges facing pharmacy education in the school and how best can they be tackled?
Faculty of Pharmaceutical Sciences ABU, Zaria, is no doubt one of the best schools of pharmacy, not only in Nigeria but around the world. The faculty started under the Faculty of Sciences, awarding BSc. Pharmacy; but over the years it has developed into B. Pharm. awarding faculty. We are hoping that the recent approval of the PharmD. Programme will take effect soon.
Challenges are inevitable; they are everywhere. As the students’ union leader, I interact with so many students, and the most common problem I often hear students complain about is the archaic method of teaching through dictation of notes, without adequate explanation by some lecturers. The world is more of a global village due to the influence of information technology; so, audio-visual teaching and other modern techniques are now the order of the day. Despite the availability of modern teaching aids, well-equipped laboratories and the digitalisation policy by the university, the archaic method of teaching continues to cause much hardship for students.
Accommodation problem is another major challenge being faced by pharmacy students, especially those in 300 level, in ABU. All 300 level students are not entitled to accommodation on campus, perhaps because they go on Industrial Training and Teaching Practice at this level. But 300 level pharmacy students do not participate in any out-of-school programmes as such. So it is unfair and unjust to deny them accommodation on campus. Through this policy, pharmacy students are made to suffer unnecessary hardship. We have been complaining over the years, but nothing has been done to solve this problem. I think a major solution to this problem would be provision of a hostel, specifically for pharmacy students. In this regard, pharmaceutical industries and well-meaning pharmacists may have to come to our aid.
The Pharmacists Council of Nigeria (PCN) recently accredited the Faculty of Pharmaceutical Sciences in your school, alongside those of other 17 universities. How do you feel about this development?
I feel more than excited that our school has met the accreditation standard required by the PCN. Since inception of my pharmacy education in ABU, I have trusted the capacity of the school because the faculty staff are up to date, the students are ready to learn, and above all, the faculty management is ever ready to support any development that will move the faculty forward. So we thank almighty God for this achievement.
Here in the north, the schools of pharmacy are very few, compared to the south; so this makes it very difficult to secure admission easily. Secondly, when I was at the PANS national convention which held at Nnamdi Azikwe University, Anambra in 2016, I noticed that the interaction and moral upbringing of pharmacy students in the southern part of Nigeria compared to ours is not the same with ours. I think the reason is because we have Moral Philosophy being taken as a course here; so those of us here hardly discriminate on the basis of gender or regional differences. I hope this is also applicable in other parts of the country.
I would consider community practice. As I said earlier, I want to see myself very close to orphans, almajiris, people with disabilities and those with mental health challenges. Community pharmacy, I think, can bring me closer to these categories of people. I also hope to help in fighting drug abuse and misuse.
By the time I would be leaving office, I would love to see a PANS that has become far better than I met it. I am concerned about leaving behind a long-lasting legacy that would continue to have positive impacts on pharmacy students even when I am no longer here.
Pharm. Oladipupo Taofik Odukoya is the founder and chief executive officer of Vanguard Pharmacy Limited, one of the fastest growing pharmacy, supermarket and veterinary chain stores in Southwest, Nigeria.
An astute professional, Odukoya possesses a rich educational background, which includes a bachelor’s degree in Pharmacy from Obafemi Awolowo University and a master’s degree in the same programme from the University of Ibadan. He further bagged a business certification in Budgetary Control and Business Administration from Lagos Business School. He is currently a doctoral researcher in Business Administration at Walden University, Minneapolis, in the USA with a view to earning a Doctor of Business Administration (DBA).

With over 15 years’ experience in pharmacy practice, Odukoya is a top performing pharmaceutical management consultant, offering professional expertise in entrepreneurship, business management, market development and customer relations.
In recognition of his hard work and contribution to the growth of pharmacy practice, he has been conferred with various awards, including: Pfizer Award of Excellence in collaboration by the Pharmaceutical Society of Nigeria; Pharmalliance Inspiration Award and Award of Excellence by the Pharmaceutical Association of Nigeria Students (PANS).
Odukoya’s work experience comprises stints with foremost pharmaceutical giants like May & Baker and Nigeria-German Chemicals Plc, where he spent well over five years building his reputation as a top-performing market development staff. Among other proficiencies, he specialises in creating strong product identity and applying unique selling techniques in perpetuating corporate growth.
Odukoya has been successfully running his Vanguard pharmacy business for the past 11 years, with an annual growth rate that validates his judicious use of experience, skill acquisition and academic achievement.
Vanguard Pharmacy started out in a 30 square meters store in 2006 before moving to its current head office in 2011. It subsequently gave rise to the second branch in Ventura Mall, Ibadan on 19 July 2015 and also its Abeokuta branch 10 September 2016. Odukoya recently opened up his fourth branch in Osogbo last December and still hopeful of expanding the stores across board.
Married to Bolajoko Odukoya (now executive director of Vanguard Pharmacy), the couple is blessed with children.
Curbing the endemic abuse of alcohol and illicit drugs is a major challenge in most countries of the world. According to the 2016 World Drug Report published by the United Nations Office of Drug and Crime, there are approximately 247 million drug users worldwide.
One of the significant issues concerning drug abuse is the high risk for developing an addiction. Efforts by researchers to find an effective treatment for drug addiction had proved abortive for years – until Professor Bankole Johnson, a Nigerian-American Professor of Psychiatry, Pharmacology and Neurology discovered that the solution was in topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist.
Today he is widely acclaimed as a pioneer in the development of medications for the treatment of alcohol, as well as being one of the world’s leading authorities on the subject of drug addiction. He is also a licensed physician and board-certified psychiatrist throughout Europe and the United States and served as Alumni Professor and Chairman of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia.

Publication and recognition
Prof. Johnson’s research paper on his topiramate findings was published in 2007 in the Journal of the American Medical Association (JAMA) and titled “Topiramate for treating alcohol dependence: a randomised controlled trial”. Soon after, the work gained national and international media attention. The study results were featured on several media outlets and brought him greater recognition. He appeared in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences in the year 2007. He has been listed in “Best Doctors in America” in 2007, 2009-2010, by Best Doctors Inc.
Interestingly, that discovery by Prof. Johnson was just the culmination of all the efforts he had made towards finding a lasting solution to the problem of addiction. In fact, as far back as 2001, his efforts had started to gain recognition and he had been given the Dan Anderson Research Award from the Hazelden Foundation for his “distinguished contribution as a researcher who has advanced the scientific knowledge of addiction recovery.” Two years later, he was inducted into the Texas Hall of Fame for his contributions to science, mathematics, and technology.
Educational background
Prof. Johnson was born on 5 November 1959 in Nigeria. In 1970, after the Nigerian civil war, he gained admission into King’s College in Lagos and received his senior secondary certificate in 1975. He also received a general diploma at Davies’ College in Sussex, England, followed by a diploma in French Studies at the Institute Catholique de Paris in Paris, France.
He was admitted into the University of Glasgow, Scotland in 1977 and graduated in 1982 with a Medicinae Baccalaureum et Chirurgie Baccalaureum degree. He went on to specialise in psychiatry at the Royal London and Maudsley and Bethlem Royal Hospitals, and to train in research at the Institute of Psychiatry (University of London).
In 1991, he graduated from the University of London with a Master of Philosophy degree in neuropsychiatry. He conducted his doctoral research at Oxford University and obtained a doctorate degree in medicine, Medicinae Doctorem, from the University of Glasgow in 1993. Most recently, in 2004, he earned his Doctor of Science degree in medicine from the University of Glasgow – the highest degree that can be granted in science by a British university.
Career
In 1993, Prof. Johnson joined the faculty at the University of Texas Health Science Centre in Houston and later became the deputy chairman for research and chief of the division of Alcohol and Drug Addiction in the Department of Psychiatry at the University of Texas Health Science Centre in San Antonio in 1998.
In 2002, the erudite researcher received the Distinguished Senior Scholar of Distinction Award from the National Medical Association. He also received the American Psychiatric Association Distinguished Psychiatrist Lecturer Award, in 2006 for outstanding achievement in the field of psychiatry as an educator, researcher, and clinician.
Prof. Johnson is a recipient of the Solomon Carter Fuller Award (2009) from the American Psychiatric Association which honours individuals who have pioneered in an area that has benefited significantly the quality of life for black people. He also received the Jack Mendelson Award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in 2013.
Prof. Johnson has served as a board member of many prestigious medical councils and institutions in the United States. These include Medications Development Subcommittee of NIDA’s Advisory Council on Drug Abuse, (2004–2007); Extramural Advisory Board for NIH/NIAAA, (2004–present); and Medications Development Scientific Advisory Board for NIH/NIDA, (2005–2009).
In September 2004, Prof. Johnson accepted an appointment to serve as Alumni Professor and Chairman of the Department of Psychiatric Medicine at the University of Virginia. He became a fellow of the Royal College of Psychiatrists in 2007. In 2009 Johnson was named associate editor of the editorial board of The American Journal of Psychiatry, and from 2010 to 2011 he served as field editor-in-chief of Frontiers in Psychiatry.
Research focus
Prof. Johnson’s research focus is on the neuro-psychopharmacology of addiction. His work integrates the neuroscience and behavioural aspects of addiction medicine with the goal of formulating a more thorough understanding of the basis of drug-seeking behaviour and developing effective treatments.
The focal point of his research is the role and interaction between midbrain monoamine systems with a focus on serotonin, gamma-aminobutyric acid (GABA)/glutamate and dopamine.
One of the interesting things about alcohol dependence is that alcohol itself is a weakly-addictive drug which has no receptors in the brain, unlike other psychoactive drugs. If it was powerfully addictive, almost everybody in the world would be addicted to alcohol. 60 per cent of alcohol-dependence is inherited and about 40 per cent is acquired. Treatment outcomes vary in different individuals because only the acquired traits of the alcoholics are usually considered. This means that if you don’t have a specialised pharmacological treatment of any kind, then you would only be working on the 40 per cent of the disease, which is not particularly effective.
Another interesting fact is that alcohol dependence has a very high spontaneous remission rate, according to Prof. Johnson. This means that, of any given four patients with alcohol dependence, one of them will recover spontaneously in one year.
Prof. Johnson seeks to focus his treatment on the ambivalent, weak-willed persons who don’t really want treatment, because they’re the most vulnerable. His current research involves clinical trials and human laboratory studies, and includes neuroimaging and molecular genetics.
He now incorporates neuroimaging evaluations into his drug interaction studies to identify the site-specific effects of abused drugs and to evaluate the effectiveness of potential medications for the treatment of addiction. Current studies include a clinical trial aimed at determining the effectiveness of ondansetron, a serotonin-3 antagonist, for the treatment of subtypes of alcoholism, as well as a human laboratory project trying to elucidate the effects of naltrexone and acamprosate on hepatic and renal function in alcohol-dependent individuals.
References:
Wikipedia: https://en.wikipedia.org/wiki/Bankole_Johnson
Differentbrains.org: http://differentbrains.org/neurodiversity-overcoming-addiction-interview-dr-bankole-johnson/
http://www.medschool.umaryland.edu/profiles/Johnson-Bankole/
The quest to improve inter-professional collaboration among healthcare professionals (HCP) received a major boost recently, with the launch of the IQVIA HCP Space, an online networking platform that could prove to be the long sought panacea for fostering harmony in the Nigerian healthcare system.
A careful analysis of the nature, structure, scope and objectives of the new networking platform shows that it is a trailblazing bridge-building tool that can help enhance not just collaboration among healthcare providers but also serve as a great means of enhancing efficiency, capacity utilisation and quality healthcare delivery to patients in the nation’s healthcare sector. This is because, to achieve better and desired healthcare outcomes for patients, healthcare professionals must work together in harmony and eschew competition while embracing collaboration. This is the trend in developed climes that are making giant strides in healthcare delivery and Nigeria cannot afford to continue to lag behind.

Indications began to emerge that the platform was poised to be historic and revolutionary in the history of the Nigerian health sector when key leaders of the various healthcare professions in the country jointly signed a Memorandum of Understanding (MoU) to pledge their commitment to support the initiative and other measures aimed at promoting collaboration and teamwork in the health sector. The signatories included Prof. Mike Ogirima, president, Nigeria Medical Association (NMA); Pharm. Ahmed Yakasai, president, Pharmaceutical Society of Nigeria (PSN); and Comrade Abdulrafiu Adeniji, president, Nigerian Association of Nigerian Nurses and Midwives (NANNM), Lagos State.
We commend the gestures of these healthcare leaders, as well those of the creators of this ground-breaking initiative; and call on all other stakeholders in the health sector and, indeed, all Nigerians to make it a holistic success. This is not just because of the potentialities of the platform but because of its timeliness. This is the digital age and utilising the digital platform for interprofessional collaboration is no doubt the best way to go at this time.
It is equally noteworthy that the IQVIA HCP Space launch and the signing of the MoU by healthcare leaders is a culmination of previous efforts aimed at promoting inter-professional collaboration by stakeholders. The breakthrough began with the joint conference of the Association of Nigerian Physicians in the Americas (ANPA) and the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) held in Las Vegas in 2016, and followed up by the epoch-making symposium organised by the Nigeria Academy of Pharmacy in 2017, which was graced by most of the leaders of the different health groups in the country. It is thus gratifying that those noble efforts are moving for the realm of dreams to realities with the launch of this online platform.
We urge all health professionals and stakeholders in the sector not to allow the IQVIA HCP Space innovation to be just another layer in the talk of inter-professional collaboration in the nation. It must be embraced as a game-changer that will take this much needed partnership for progress by healthcare practitioners from mere talk to tangible and beneficial actions.
We also urge the regulators of all the healthcare professional groups, the Pharmacists Council of Nigeria (PCN), the Medical and Dental Council of Nigeria (MDCN), the Nursing and Midwifery Council and others to also seize this as an opportunity to work together not just for professional development but for the good of the patient.
By Ayodeji Oni
All over the world, patients seek cost-effective medicines. This means that they want drugs that are affordable and are still effective. This is valid, as it is standard practice to make treatment cost-effective. Generic brands are one way to meet this need, as they do not go through the discovery, development, research and clinical trial process of the branded drugs, and are therefore produced and sold at lower prices.
Branded drugs, on the other hand, are the innovators of the compound; they undergo laboratory tests, carry out research and development of the drug, and conduct clinical trials and market survey before being released into the market. This process is very expensive, as the estimated cost of producing a new drug is 802 million dollars. For the pharmaceutical companies involved to recoup their funds, they are given the patent rights that last for a certain period to make back the funds spent on the development of the new drug. This would translate into high cost of the drug to the final consumer.
When comparing generics with branded drugs, the most important factor to consider is the bioequivalence profile, which, simply put, is the rate and extent to which the active ingredient is available at the site of drug action when administered at the same dose. This also means that the rate at which these drugs are metabolised and distributed in the plasma, and eliminated in the blood, must be the same. Hence, the next time you want to purchase generics, do so from a registered pharmacy as this will ensure you get safer generics. Other similar characteristics branded drugs and generics should have include good quality packaging, same strength of active ingredients, same taste if in syrup form, and the same name of active ingredient.

Some people’s scepticism about using generic drugs is valid as there are some that fall short of the above primary and secondary characteristics. It is however the prerogative of a registered pharmacist to guide the patient on making the best choice.
It is a World Health Organisation pro public health initiative for drugs to be prescribed using generics only. This helps with simplification of language to reduce medication error and also help reduce any bias to dispense only one particular brand/generic that may be adulterated or be harmful to patients. A registered pharmacy only procures approved standards of generics, making it less likely to come across counterfeit medicines there.
However, drugs with narrow therapeutic index (e.g. antiepileptic medicines) usually should not be substituted, as a little deviation in bioequivalence could cause therapeutic failure. However, the same level of observed deviations could sometimes be seen between different batches of the same brands, too.
With the wide range of generics flooding the market, the monitoring of standards to maintain the similarities between them and their branded counterparts is questionable. Much more effort must be directed towards ensuring quality control of generic alternatives. The National Agency for Food and Drug Administration and Control (NAFDAC) is saddled with the responsibility of carrying out comprehensive tests to achieve this, thereby ensuring that the approval of these generic brands into the market is up to standard.
It is recommended that pharmacists, retailers and wholesalers ensure proper purchasing management and strict regulatory measures. Also, it is important that patients know the actual content of their drugs instead of only the brand names; this will enable the pharmacist give the best advice on their medications.
The need to creating avenues to enlighten the general public on the need to patronise only registered pharmacies cannot be over-emphasised, as they provide the most suitable range of branded and generic medicines to meet the needs of their communities.
Life is a journey. It has a beginning and an end. Each year brings us a fresh opportunity to start all over again and work towards achieving our purpose in life. Since we use the Gregorian calendar to count our days on earth, it is quite logical to plan for your next level at the beginning of the year.
But then, it must be said that 80 per cent of people who set goals for themselves for the year often abandon it by second week of February. The questions include, why do people easily give up on their goals? Why are few people moving from strength to strength year in, year out, while many other folks are stuck for years at a particular level? What differentiates between the winners and the masses?
I’ve dedicated 11 years of my life to studying personal growth and what makes the difference between the champions and the losers. Based on personal experiences and result- oriented principles and practices that have worked for thousands of individuals from all walks of life for ages across the globe, there are three practical steps you can take to become a winner and make your 2018 your best year ever.

I believe 2018 can be a remarkable year for you if you efficiently apply the above principles. It looks too simple. But don’t let the simplicity of the ideas above deceive you. True genius lies in simplicity. The above tips helped me to achieve amazing results in 2017 and they have helped thousands of achievers across our world to do the same. They will help you get amazing results if you apply them religiously.
I hope that by the end of 2018, when you look back to reflect on your performance throughout the year, you will be so proud of what you have achieved and who you have become because you’ve asked intelligently, believed wholeheartedly and received carefully.
ACTION PLAN: Write down your goals, read them out twice daily and go to work on them. Use affirmations and imagination to build your belief system. Stay hungry
AFFIRMATION: I have made 2018 my best year ever. I am blessed and highly favoured.
Editor-In-Chief of the Association of Community Pharmacists of Nigeria (ACPN) Lagos State Chapter, Pharm. Paul Olatunbosun Owolabi, has raised the alarm over what he calls “incursion into pharmacy practice by charlatans and quacks,” saying the impact of these groups is like an infectious disease that has entered into the system, silently killing the practice. Speaking with Pharmanews in an exclusive interview recently, Pharm. Owolabi, managing director, Lighthouse Pharmacy, Ifako/Ijaiye, Lagos State, equally tasked the federal government to help curb the rate at which young people are exposed to hard drugs in the country. Excerpts:
As an experienced community pharmacist, how would you assess pharmacy practice in this part of the state?

I have practised in almost all the technical arms of the Pharmaceutical Society of Nigeria (PSN), but community practice seems to be the most challenging because almost everybody in this part of the world sees it is a business venture where they can invest money and make profit at will, without minding the professionalism aspect of it. So, the practice in this part of the country is greatly challenged.
Tell us about your outfit, Lighthouse Pharmacy. What is the philosophy behind its establishment and where do you hope to take the business to in five years?
We started about seven years ago to render pharmaceutical services to members of the public in our neighbourhood, both far and near, while prioritising family wellness, drug and health Information. So, in five years’ time by the grace of God, we hope to have more branches and many more services
What is Lighthouse Pharmacy doing differently as at present that stands you out in community pharmacy practice?
As I mentioned earlier, family wellness is our major priority and we are doing this with special benefit for the senior citizens, specifically those above 65 years, widows, and others. This is one of the aims and objectives of our non-governmental organisation called Charity Foundation, which is being run in partnership with my wife here in Lagos, Ifako Ijaye Local Government, to be precise.
As the new editor-in-chief of Lagos ACPN, tell us about your new position.
It’s almost a year now that I came into the office, so the position is an opportunity to serve pharmacy profession, passing vital and valuable information that will enhance the practice to colleagues through newsletters, journals, social media, online channels, newspaper publications and other medium, in such a way that the general public can also have access to information at their level. However, sponsorship is our major challenge, as there are projects to be funded majorly through adverts and donations, so that copies can be distributed free to all technical group members, even government agencies.
It can be tough combining community pharmacy practice with active involvement in ACPN activities. How do you intend to manage this?
Very tough indeed, it is a big sacrifice that I have to make, but I have the passion to contribute my little efforts, knowledge and experience in organising and forming a good structure to make things work, irrespective of the challenges.
What do you think is wrong with the way community pharmacy is being practised in Nigeria?
Most people think it is a trade business and not a professional service. Unfortunately we have allowed and are still licensing traders who are like an infectious disease to enter into the system. I pray they will not turn into a “cancer” before we realise that no matter how well you decorate a pig, it will still find its way into the mud. In advanced countries, only trained professionals handle drugs; but here in Nigeria, it is a free-for-all.
Drug abuse has been on the increase in recent times. Tell us your experience on this, and how it can be curtailed?
This is a full topic of discussion on its own because drug abuse in the 21st century has taken new dimensions. Substances that are meant for different use are being abused. This involves males and females, young and old, men and women, married and single. Recently the Nigerian House of Assembly raised the alarm over the rate at which cough syrups with codeine preparations are being abused by various categories of the population in the north. Some use them as beverages stored in the refrigerator. Tramadol abuse is on the increase. The heart-breaking thing is that a good percentage of the youth who are the leaders of tomorrow may end up facing the consequences of drug abuse, giving them no hope of doing well in future. Most become criminals like armed robbers, assassins, suicide bombers and rapists just to mention few.
Pharmacists who are the custodians of drugs have a major role to play. Drug manufacturers and community pharmacists do not need to wait for government policies or agencies before we do what is right. We must control the manufactured quantities, sales, distribution and dispensing of codeine-containing cough syrups, using our professional judgments, not allowing monetary gains to blindfold us.
How cordial is your relationship with the people of this community, and how lucrative is pharmacy business here?
God has helped us to be relevant in this community as we have intervened in many hopeless medical situations. Most of the times, our opinions are being used when certain decisions are to be made in the community. Our services and business angle is increasing on daily basis and people are willing to recommend us to their neighbours.
It was celebration of life for the Chief Executive Officer of Therapeutic Laboratories Nigeria Ltd., Mr Joginder Singh Lalvani, as he clocked 90 years on 15 February, 2018.The birthday ceremony, which was well graced by his family and friends, was a 3-day event, held in India.
Born on 15 February 1928, in India, he came to Nigeria as a young adult, then established his company, Therapeutic Laboratories Nigeria Ltd.

Therapeutic was incorporated in 1978 and started business as importer of finished pharmaceuticals. Local manufacturing started in 1988 with strict adherence to quality standards in accordance with Good Manufacturing Practice.